Clinical and Molecular Epidemiology

C-reactive protein and risk of venous thromboembolism: Results from a population-based case-crossover study
Gro Grimnes, Trond Isaksen, Ynse Ieuwe Gerardus Vladimir Tichelaar, Jan Brox, Sigrid Kufaas Brækkan, John-Bjarne Hansen

Haematologica Apr 2018, haematol.2017.186957; DOI: 10.3324/haematol.2017.186957
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
Ida Martinelli, Maria Abbattista, Paolo Bucciarelli, Armando Tripodi, Andrea Artoni, Francesca Gianniello, Cristina Novembrino, Flora Peyvandi

Haematologica Mar 2018, haematol.2017.185132; DOI: 10.3324/haematol.2017.185132
Toxicities and outcomes of 621 ibrutinib-treated chronic lymphocytic leukemia patients in the United States: a real-world analysis
Anthony R Mato, Chadi Nabhan, Meghan C. Thompson, Nicole Lamanna, Danielle M. Brander, Brian Hill, Christina Howlett, Alan Skarbnik, Bruce D. Cheson, Clive Zent, Jeffrey Pu, Pavel Kiselev, Andre Goy, David Claxton, Krista Isaack, Kaitlin H. Kennard, Colleen Timlin, Daniel Landsburg, Allison Winter, Sunita D. Nasta, Spencer H. Bachow, Stephen J. Schuster, Colleen Dorsey, Jakub Svoboda, Paul Barr, Chaitra S. Ujjani

Haematologica Feb 2018, haematol.2017.182907; DOI: 10.3324/haematol.2017.182907
Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis
Sameer A. Parikh, Kari G. Chaffee, Melissa C. Larson, Paul J. Hampel, Timothy G. Call, Wei Ding, Saad S. Kenderian, Jose F. Leis, Asher A. Chanan-Khan, Michael J. Conte, Deborah Bowen, Susan M. Schwager, Susan L. Slager, Curtis A. Hanson, Neil E. Kay, Tait D. Shanafelt

Haematologica Feb 2018, haematol.2017.183194; DOI: 10.3324/haematol.2017.183194